Compare CWH & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CWH | YDES |
|---|---|---|
| Founded | 1966 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Retail-Auto Dealers and Gas Stations | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 662.1M | 543.0M |
| IPO Year | 2016 | 2024 |
| Metric | CWH | YDES |
|---|---|---|
| Price | $6.54 | $4.69 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $15.78 | N/A |
| AVG Volume (30 Days) | ★ 2.1M | 42.4K |
| Earning Date | 04-29-2026 | 05-12-2026 |
| Dividend Yield | ★ 5.41% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 3.99 | N/A |
| Revenue | ★ $4,792,017,000.00 | N/A |
| Revenue This Year | $4.63 | N/A |
| Revenue Next Year | $5.72 | N/A |
| P/E Ratio | $1.63 | ★ N/A |
| Revenue Growth | ★ 11.83 | N/A |
| 52 Week Low | $5.49 | $1.70 |
| 52 Week High | $18.34 | $25.00 |
| Indicator | CWH | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 52.19 | 78.79 |
| Support Level | $6.30 | $4.73 |
| Resistance Level | $6.94 | $5.36 |
| Average True Range (ATR) | 0.31 | 0.48 |
| MACD | 0.06 | 0.28 |
| Stochastic Oscillator | 54.22 | 92.58 |
Camping World Holdings Inc is a retailer of RVs and related products and services. The company offers RV products and services with a national network of RV dealerships, service centers and customer support centers. It operates in two reportable segments: Good Sam Services and Plans; and RV and Outdoor Retail. The majority of the revenue is derived from RV and Outdoor Retail segment that derives revenue from the sale of new and used RVs; commissions on the finance and insurance contracts related to the sale of RVs; the sale of RV service and collision work; the sale of RV parts, accessories, and supplies; the sale of outdoor products, equipment, gear and supplies; and the sale of Good Sam Club memberships and co-branded credit cards.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.